Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 7,756,494 |
|
|||||
| News | - | ||||||
| Day High | 131.91 | Low High |
|||||
| Day Low | 130.13 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Merck and Co Inc | MRK | NYSE | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.24 | 0.18% | 130.96 | 16:13:59 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 130.13 | 130.13 | 131.91 | 131.20 | 130.72 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 93,818 | 7,756,494 | US$ 131.13 | US$ 1,017,080,592 | - | 99.14 - 133.10 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:30:00 | 1,147,876 | US$ 131.20 | USD |
Merck (MRK) Options Flow Summary
Merck and Co Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 332.28B | 2.53B | - | 60.12B | 365M | 0.14 | 910.48 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Merck News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 125.71 | 132.80 | 124.89 | 127.74 | 8,865,624 | 5.25 | 4.18% |
| 1 Month | 131.68 | 132.80 | 124.50 | 127.40 | 6,829,302 | -0.72 | -0.55% |
| 3 Months | 126.88 | 133.10 | 119.41 | 125.72 | 8,302,256 | 4.08 | 3.22% |
| 6 Months | 103.21 | 133.10 | 99.80 | 116.61 | 8,394,450 | 27.75 | 26.89% |
| 1 Year | 115.33 | 133.10 | 99.14 | 113.16 | 7,729,144 | 15.63 | 13.55% |
| 3 Years | 78.00 | 133.10 | 70.89 | 93.42 | 9,978,009 | 52.96 | 67.90% |
| 5 Years | 76.64 | 133.10 | 65.25 | 88.33 | 9,974,436 | 54.32 | 70.88% |
Merck Description
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States. |
